The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.

We support low- and middle-income countries to generate, share and use data to improve antimicrobial usage and encourage investment in antimicrobial resistance (AMR).

Since 2017, the Fleming Fund has adopted a comprehensive systems-strengthening approach, investing in laboratory infrastructure, human…

Fleming Fund country grantees completed political economy analyses to inform implementation in phase 2 of the programme, 19 of which are…

Papua New Guinea (PNG) has taken an important step toward securing the long-term sustainability of its antimicrobial resistance (AMR)…

The latest paper from the Fleming Fund Regional Grant team, GEAR up, argues that current action on AMR fails to adequately address the…

26: Active Country Grants
20: Active Regional Grants
321: Supported surveillance sites
30: Countries we work in (more than)
170: National Action Plans developed with Fleming Fund support
155: Countries have supplied data on use of antimicrobial medicines in animals to WOAH database

The irrational use of antimicrobials is a global challenge. Prescribing the right drugs, in the correct dosage with clear instructions, is…

This report provides analysis and lessons from implementing the Fleming Fund, drawn from a series of country case studies, to support…

To mark this year’s World Antimicrobial Awareness Week (WAAW) theme, we ask some of our partners what the Fleming Fund has meant to them.

The Fleming Fund was created in 2015-16 to strengthen national AMR surveillance systems in low- and middle-income countries (LMICs) and…